发明授权
- 专利标题： Polymorphs of atomoxetine hydrochloride
- 专利标题（中）： 盐酸阿托西汀的多晶型物
-
申请号： US11187349申请日： 2005-07-21
-
公开(公告)号： US07473804B2公开(公告)日： 2009-01-06
- 发明人: Judith Aronhime , Stefano Bianchi , Eugenio Castelli , Paola Daverio , Silvia Mantovani , Adrienne Kovacsne-Mezei
- 申请人： Judith Aronhime , Stefano Bianchi , Eugenio Castelli , Paola Daverio , Silvia Mantovani , Adrienne Kovacsne-Mezei
- 申请人地址： IT Bulciago (LC)
- 专利权人： Teva Pharmaceutical Fine Chemicals s.r.l.
- 当前专利权人： Teva Pharmaceutical Fine Chemicals s.r.l.
- 当前专利权人地址： IT Bulciago (LC)
- 代理机构： Kenyon & Kenyon LLP
- 主分类号： C07C213/08
- IPC分类号： C07C213/08 ; C07C217/62 ; A61K31/135
摘要：
The present invention provides novel crystalline polymorph forms of atomoxetine hydrochloride denominated Forms B and C and methods for their preparation, as well as methods for the preparation of Form A. The present invention provides pharmaceutical compositions that comprise atomoxetine hydrochloride Form B, Form C, or mixtures thereof that can be used to treat attention deficit/hyperactivity disorder.
公开/授权文献
- US20060079581A1 Polymorphs of atomoxetine hydrochloride 公开/授权日：2006-04-13
信息查询
